485 related articles for article (PubMed ID: 8530621)
21. Aromatase deficiency and estrogen resistance: from molecular genetics to clinic.
Bulun SE
Semin Reprod Med; 2000; 18(1):31-9. PubMed ID: 11305285
[TBL] [Abstract][Full Text] [Related]
22. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
23. Tall stature without growth hormone: four male patients with aromatase deficiency.
Rochira V; Zirilli L; Maffei L; Premrou V; Aranda C; Baldi M; Ghigo E; Aimaretti G; Carani C; Lanfranco F
J Clin Endocrinol Metab; 2010 Apr; 95(4):1626-33. PubMed ID: 20164294
[TBL] [Abstract][Full Text] [Related]
24. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
25. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
[TBL] [Abstract][Full Text] [Related]
26. Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence.
Belgorosky A; Guercio G; Pepe C; Saraco N; Rivarola MA
Horm Res; 2009; 72(6):321-30. PubMed ID: 19844120
[TBL] [Abstract][Full Text] [Related]
27. Hypothesis: Persistently elevated hCG causes gestational ovarian overstimulation associated with prolonged postpartum hyperandrogenism in mothers of aromatase-deficient babies.
Riedl S; Springer A; Häusler G; Price G; Richter-Unruh A; Stener-Victorin E; Wudy SA
J Clin Endocrinol Metab; 2013 Aug; 98(8):3115-20. PubMed ID: 23824416
[TBL] [Abstract][Full Text] [Related]
28. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
[TBL] [Abstract][Full Text] [Related]
29. Genetic mutations resulting in estrogen insufficiency in the male.
Simpson ER
Mol Cell Endocrinol; 1998 Oct; 145(1-2):55-9. PubMed ID: 9922099
[TBL] [Abstract][Full Text] [Related]
30. Aromatase expression in health and disease.
Simpson ER; Zhao Y; Agarwal VR; Michael MD; Bulun SE; Hinshelwood MM; Graham-Lorence S; Sun T; Fisher CR; Qin K; Mendelson CR
Recent Prog Horm Res; 1997; 52():185-213; discussion 213-4. PubMed ID: 9238853
[TBL] [Abstract][Full Text] [Related]
31. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
[TBL] [Abstract][Full Text] [Related]
32. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
[TBL] [Abstract][Full Text] [Related]
33. The aromatase cytochrome P-450 and its clinical impact.
Meinhardt U; Mullis PE
Horm Res; 2002; 57(5-6):145-52. PubMed ID: 12053085
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.
Ito Y; Fisher CR; Conte FA; Grumbach MM; Simpson ER
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11673-7. PubMed ID: 8265607
[TBL] [Abstract][Full Text] [Related]
35. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.
Smith EP; Boyd J; Frank GR; Takahashi H; Cohen RM; Specker B; Williams TC; Lubahn DB; Korach KS
N Engl J Med; 1994 Oct; 331(16):1056-61. PubMed ID: 8090165
[TBL] [Abstract][Full Text] [Related]
36. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
37. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
38. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
39. Aromatase deficiency in a male patient - Case report and review of the literature.
Miedlich SU; Karamooz N; Hammes SR
Bone; 2016 Dec; 93():181-186. PubMed ID: 27693882
[TBL] [Abstract][Full Text] [Related]
40. Aromatase deficiency, a rare syndrome: case report.
Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
